RSS

Bayer

TissUse and Bayer have entered into a collaborative agreement for the development of a liver-endocrine tissues assay, using TissUse’s Multi-Organ-Chip (MOC) technology. more

Technology

As pharma encounters massive shifts in public perception, which is seemingly negative in the current climate, Nick Johns from ConsumerSafety.org, looks at the focus of pharma in the US and how shifting this could benefit public perception more

Opinion

Technology specialist DelsiTech and life science company Bayer have collaborated to develop a new drug delivery technology for Bayer’s compounds in ophthalmology. more

News

Abbvie, Sanofi and Novo Nordisk seens as most reputable pharma companies in the UK and industry as a whole ranked third most reputable by general public more

News

Bayer and Orion today announced the expansion of the global clinical development programme for an investigational androgen receptor (AR) antagonist in the area of prostate cancer more

News

Bayer and Biontech, a immunotherapy company headquartered in Mainz have entered into an agreement to develop novel, first-in-class mRNA vaccines and therapeutics specifically for animal health applications. more

News

Innovation – it’s everywhere in the pharmaceutical sector. Sometimes it’s a small step but more often it's continued effort into drug development, delivery or research that leads to the constant stream of new products and formulations more

News

Tom Homer, Telstra, looks at the maturing market of digital health and partnerships between life science and technology companies more

Opinion

EPM looks at company relationships in the pharma sector to see which companies are teaming up for new developments and which companies are ‘taking a break’ more

Opinion

Bayer and Regeneron Pharmaceuticals collaborate on a combination therapy to treat eye diseases more

News

Bayer has teamed up with the Universities of Dundee and Cape Town (UCT) in an effort to develop new treatments for tuberculosis (TB) more

News

Bayer HealthCare has launched a "Grants4Apps Accelerator 2015" program in Berlin, awarding grants to five digital health startups more

BayerLeverkusen2_BAG00020793.ashx.jpg

Photo copyright Bayer

Bayer is reported to be considering the sale of its diabetes device business in favour of a focus on faster-growing medicines, according to Bloomberg, which cites “people with knowledge of the matter” as its source. more

News

Bayer has completed the acquisition of the consumer care business of US pharma group Merck & Co. more

News

BayerLeverkusen2_BAG00020793.ashx.jpg

Photo copyright Bayer

Bayer will float its MaterialScience business, which produces polymer materials, on the stock market as a separate company. more

News